David Altshuler, EVP, Global Research and CSO: Vertex Pharmaceuticals VRTX Planned sale · Filed 25/03/13

Trade details

Type: Planned sale notice
Stock: Vertex Pharmaceuticals VRTX
Person: David AltshulerEVP, Global Research and CSO
Planned sale date: 25/03/13
Filed: 25/03/13

More to sell after $4.8M in 3 months

Vertex Pharmaceuticals trades, last 26 weeks

What else happened in Vertex Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/02/11~25/04/12

David Altshuler's recent trades

David AltshulerEVP, Chief Scientific Officer
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$22.1K
52 sh
$22.1K
Filed 25/05/19
Traded 25/05/15
David AltshulerEVP, Chief Scientific Officer
Planned sale10b5-1 planVertex Pharmaceuticals
Planned sale10b5-1 plan
Vertex Pharmaceuticals
VRTX
$22.1K
52 sh
$22.1K
Filed 25/05/15
Traded 25/05/15
David AltshulerEVP, Chief Scientific Officer
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.6M
3,231 sh
$1.6M
Filed 25/03/17
Traded 25/03/13
David AltshulerEVP, Chief Scientific Officer
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.6M
3,231 sh
$1.6M
Filed 25/03/12
Traded 25/03/10
David AltshulerEVP, Global Research and CSO
Planned sale10b5-1 planVertex Pharmaceuticals
Planned sale10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.6M
3,231 sh
$1.6M
Filed 25/03/10
Traded 25/03/10

David Altshuler, EVP — plans to sell 3,231 sh of Vertex Pharmaceuticals VRTX · $1.6M · around 03/13 · 10b5-1 plan | Whalegun